Mediwound (MDWD) to Release Quarterly Earnings on Monday
Mediwound (NASDAQ:MDWD) will post its quarterly earnings results before the market opens on Monday, March 19th. Analysts expect Mediwound to post earnings of ($0.16) per share for the quarter.
Shares of Mediwound (NASDAQ MDWD) traded up $0.05 during midday trading on Wednesday, hitting $4.30. The stock had a trading volume of 4,561 shares, compared to its average volume of 28,067. Mediwound has a 1 year low of $3.56 and a 1 year high of $8.25. The stock has a market cap of $114.95, a PE ratio of -6.72 and a beta of 0.15.
A number of research analysts have recently commented on the company. ValuEngine cut Mediwound from a “sell” rating to a “strong sell” rating in a research report on Thursday, March 1st. Zacks Investment Research cut Mediwound from a “hold” rating to a “sell” rating in a research report on Thursday, January 18th. Oppenheimer set a $10.00 price target on Mediwound and gave the company a “buy” rating in a research report on Friday, December 8th. Finally, SunTrust Banks set a $9.00 price target on Mediwound and gave the company a “buy” rating in a research report on Thursday, November 16th. Two investment analysts have rated the stock with a sell rating and five have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $9.13.
Mediwound Company Profile
MediWound Ltd. is a biopharmaceutical company. The Company focuses on developing, manufacturing and commercializing therapeutics products in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. The Company’s product, NexoBrid, is indicated for the removal of dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns, also referred to as severe burns.
Receive News & Ratings for Mediwound Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediwound and related companies with MarketBeat.com's FREE daily email newsletter.